Download Free Sample Report

Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
This report contains market size and forecasts of Breast Cancer Liquid Biopsy in Global, including the following market information:

• Global Breast Cancer Liquid Biopsy Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Breast Cancer Liquid Biopsy market was valued at 330.1 million in 2021 and is projected to reach US$ 971.4 million by 2028, at a CAGR of 16.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Circulating Tumor Cells (CTCs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Liquid Biopsy include QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific, Illumina and Biocept, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Breast Cancer Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Liquid Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Liquid Biopsy Market Segment Percentages, by Type, 2021 (%)

• Circulating Tumor Cells (CTCs)
• Cell-Free DNA (CfDNA)
• Extracellular Vesicles (EVs)
• Other Circulating Biomarkers

Global Breast Cancer Liquid Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Breast Cancer Liquid Biopsy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Centers
• Laboratories

Global Breast Cancer Liquid Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Breast Cancer Liquid Biopsy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Breast Cancer Liquid Biopsy revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Breast Cancer Liquid Biopsy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• QIAGEN
• Roche Diagnostics
• Bio-Rad Laboratories
• Myriad Genetics
• Menarini Silicon Biosystems
• Genomic Health
• Thermo Fisher Scientific
• Illumina
• Biocept
• Trovagene
• Guardant Health
• RainDance Technologies
• MDx Health